Title : Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.

Pub. Date : 2005 Jan

PMID : 15663654






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: A 63-year-old man with therapy-resistant Sezary syndrome was enrolled in a multicenter trial of oral bexarotene for advanced-stage cutaneous T-cell lymphoma (CTCL). Bexarotene TSPY like 2 Homo sapiens
2 Further studies on the interaction between the skin, lymph nodes, and peripheral blood compartments during bexarotene treatment in this subset of patients with CTCL are needed. Bexarotene TSPY like 2 Homo sapiens